Singular Genomics Systems, Inc. (OMIC)

USD 19.6

(-0.56%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 2.91 Million 765 Thousand - - -
Cost of Revenue 3.46 Million 789 Thousand 1.13 Million 639 Thousand 350 Thousand
Gross Profit -558 Thousand -24 Thousand -1.13 Million -639 Thousand -350 Thousand
Operating Expenses 102.24 Million 93.46 Million 61.27 Million 27.53 Million 12.77 Million
Selling, General and Administrative Expenses 54.47 Million 47.26 Million 28.62 Million 6.28 Million 2.28 Million
Research and Development Expenses 47.76 Million 46.19 Million 32.65 Million 21.24 Million 10.48 Million
Other Expenses - - 405 Thousand - -
Cost and Expenses 105.71 Million 94.25 Million 61.27 Million 27.53 Million 12.77 Million
Operating Income -102.8 Million -93.48 Million -61.27 Million -27.53 Million -12.77 Million
Interest Expense 1.1 Million 763 Thousand 846 Thousand 718 Thousand 17 Thousand
Income Tax Expense - -2.6 Million 118 Thousand 718 Thousand 17 Thousand
Earnings before Tax -94.82 Million -90.87 Million -98.77 Million -27.94 Million -12.32 Million
Net Income -94.82 Million -88.27 Million -98.88 Million -28.66 Million -12.34 Million
Earnings Per Share Basic -39.08 -37.22 -40.95 -12.41 -5.34
Earnings Per Share Diluted -39.08 -37.22 -40.95 -12.41 -5.34
Weighted Average Shares Outstanding 2.42 Million 2.37 Million 2.41 Million 2.31 Million 2.31 Million
Weighted Average Shares Outstanding (Diluted) 2.42 Million 2.37 Million 2.41 Million 2.31 Million 2.31 Million
Gross Margin -0.19 -0.03 - - -
EBIT Margin -29.71 -117.80 - - -
Profit Margin -32.57 -115.39 - - -
EBITDA -86.49 Million -84.08 Million -60.54 Million -26.39 Million -11.95 Million
Earnings Before Tax Margin -35.31 -122.21 - - -

Income Statement Charts